These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30009705)

  • 21. Successful Treatment with a High-dose Rifampin-containing Regimen for Pulmonary Tuberculosis with a Disputed rpoB Mutation.
    Jeong DH; Kang YW; Kim JY; Han JS; Jo KW; Shim TS
    Intern Med; 2018 Nov; 57(22):3281-3284. PubMed ID: 29984742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular analysis of codon 548 in the rpoB gene involved in Mycobacterium tuberculosis resistance to rifampin.
    Horng YT; Jeng WY; Chen YY; Liu CH; Dou HY; Lee JJ; Chang KC; Chien CC; Soo PC
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1542-8. PubMed ID: 25534743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Polyphenolic Profile and Antibacterial Activity of Pomegranate Juice in Combination with Rifampin (R) against MDR-TB Clinical Isolates.
    AlMatar M; Var I; Kayar B; Eker E; Kafkas E; Zarifikhosroshahi M; Köksal F
    Curr Pharm Biotechnol; 2019; 20(4):317-326. PubMed ID: 30854955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular investigation of active binding site of isoniazid (INH) and insight into resistance mechanism of S315T-MtKatG in Mycobacterium tuberculosis.
    Srivastava G; Tripathi S; Kumar A; Sharma A
    Tuberculosis (Edinb); 2017 Jul; 105():18-27. PubMed ID: 28610784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculosis: current treatment, diagnostics, and newer antitubercular agents in clinical trials.
    Ahsan MJ; Ansari MY; Yasmin S; Jadav SS; Kumar P; Garg SK; Aseri A; Khalilullah H
    Infect Disord Drug Targets; 2015; 15(1):32-41. PubMed ID: 25246035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of isoniazid and rifampin resistance in Mycobacterium tuberculosis strains by single-strand conformation polymorphism analysis and restriction fragment length polymorphism.
    Piana A; Orrù M; Masia MD; Sotgiu G; Muresu E; Maida A
    New Microbiol; 2003 Oct; 26(4):375-81. PubMed ID: 14596348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis.
    Zhang Z; Dai F; Luo F; Zhong M; Huang Z; Hou T; Xu J
    J Orthop Surg Res; 2014 Dec; 9():124. PubMed ID: 25467069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GeneChip analysis of resistant Mycobacterium tuberculosis with previously treated tuberculosis in Changchun.
    Zhang MJ; Ren WZ; Sun XJ; Liu Y; Liu KW; Ji ZH; Gao W; Yuan B
    BMC Infect Dis; 2018 May; 18(1):234. PubMed ID: 29788948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis isolates from Eastern Poland.
    Paluch-Oles J; Kozioł-Montewka M; Magrys A
    New Microbiol; 2009 Apr; 32(2):147-52. PubMed ID: 19579691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm.
    Chakraborty S; Rhee KY
    Cold Spring Harb Perspect Med; 2015 Apr; 5(8):a021147. PubMed ID: 25877396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China.
    Jiao WW; Mokrousov I; Sun GZ; Li M; Liu JW; Narvskaya O; Shen AD
    Chin Med J (Engl); 2007 May; 120(9):814-9. PubMed ID: 17531124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of CarD with RNA polymerase mediates Mycobacterium tuberculosis viability, rifampin resistance, and pathogenesis.
    Weiss LA; Harrison PG; Nickels BE; Glickman MS; Campbell EA; Darst SA; Stallings CL
    J Bacteriol; 2012 Oct; 194(20):5621-31. PubMed ID: 22904282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Trends in tuberculosis treatment duration].
    Veziris N; Aubry A; Truffot-Pernot C
    Presse Med; 2006 Nov; 35(11 Pt 2):1758-1764. PubMed ID: 17086138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural Implications of Mutations Conferring Rifampin Resistance in Mycobacterium leprae.
    Vedithi SC; Malhotra S; Das M; Daniel S; Kishore N; George A; Arumugam S; Rajan L; Ebenezer M; Ascher DB; Arnold E; Blundell TL
    Sci Rep; 2018 Mar; 8(1):5016. PubMed ID: 29567948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
    Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A
    BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay.
    Bártfai Z; Somoskövi A; Ködmön C; Szabó N; Puskás E; Kosztolányi L; Faragó E; Mester J; Parsons LM; Salfinger M
    J Clin Microbiol; 2001 Oct; 39(10):3736-9. PubMed ID: 11574605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in catalase-peroxidase KatG from isoniazid resistant Mycobacterium tuberculosis clinical isolates: insights from molecular dynamics simulations.
    Pimentel AL; de Lima Scodro RB; Caleffi-Ferracioli KR; Siqueira VL; Campanerut-Sá PA; Lopes LD; de Almeida AL; Cardoso RF; Seixas FA
    J Mol Model; 2017 Apr; 23(4):121. PubMed ID: 28303436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rifamycin action on RNA polymerase in antibiotic-tolerant
    Saito K; Warrier T; Somersan-Karakaya S; Kaminski L; Mi J; Jiang X; Park S; Shigyo K; Gold B; Roberts J; Weber E; Jacobs WR; Nathan CF
    Proc Natl Acad Sci U S A; 2017 Jun; 114(24):E4832-E4840. PubMed ID: 28559332
    [No Abstract]   [Full Text] [Related]  

  • 40. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.